Analysis of Organelle Dynamics by Quantitative Mass Spectrometry Based Proteomics by Florian Fröhlich et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Analysis of Organelle  
Dynamics by Quantitative  
Mass Spectrometry Based Proteomics 
Florian Fröhlich, Tobias C. Walther and Romain Christiano 
Yale University School of Medicine, Department of Cell Biology 
USA 
1. Introduction 
A major goal of cell biology is to understand the dynamic interplay between different 
reactions in the cell. In eukaryotes, compartmentalization of the cytoplasm into organelles 
facilitates the coordinated execution of many cellular functions. To understand how this is 
achieved, it is important to know the protein composition of the different organelles, and to 
determine how it may change over time. In addition, the activity of many proteins is 
regulated by often reversible and dynamic post-translational modifications (PTMs). In 
recent years, proteomics has matured into a staple technique for cell biology. Modern 
approaches of proteomics rely on mass-spectrometry. Here, we build on several reviews 
(Aebersold and Mann, 2003; Choudhary and Mann, 2010; Walther and Mann, 2010) to 
summarize and highlight contemporary applications of MS-based proteomics to the analysis 
of organelle dynamics.  
2. MS-based quantitative proteomics approaches for proteins and their post-
translational modifications 
Most proteomics studies aim to not just identify proteins but to quantitate their abundance 
in different samples. In the past few years, several quantitative proteomics approaches have 
been developed to accomplish this task. 
2.1 MS-based quantitative proteomics approaches 
2.1.1 Stable isotope labeling by amino acids in cell culture (SILAC) 
The most commonly used method to quantitate proteins is stable isotope labeling by amino 
acids in cell culture (SILAC; (Ong et al., 2002)) in combination with liquid chromatography 
(LC) and tandem high resolution mass spectrometry (LC-MS/MS). Cells are labeled with 
non-radioactive heavy labeled amino acids, typically arginine and /or lysine. After cell lysis, 
extracts from differently labeled and differently treated cells are mixed and digested with a 
protease that cuts after the labeled amino acids, such as trypsin for the case of 
arginine/lysine. The resulting peptide mixture is fractionated by LC on a C18 column and 
analyzed in a high resolution mass spectrometer. The mass shift between labeled and 
unlabeled peptides allows the quantification of intensities of peptides, and based on that of 
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proteins, derived from cells differentially labeled and subjected to different conditions. Since 
chemically identical peptides are quantitated in the same spectrum, the accuracy of this 
methodology is very high. In addition, mixing samples directly after lysis limits the chance 
for experimental errors. However, in its simplest rendition, SILAC-based proteomics is 
limited to samples that can be metabolic labeled, including cells and model organisms 
(ranging from yeast to mice) (de Godoy et al., 2008; Kruger et al., 2008). Recently developed 
“spike-in” approaches that use isotope labeled cell extracts as standards for analysis of 
samples of interests from sources that cannot be labeled, such as patient samples, are 
compared. In case a single cell extract does not adequately represent a particular tissue or 
sample, several extracts can be mixed to obtain a “super-SILAC” standard (Geiger et al., 
2010). This approach of SILAC reference standards is not limited to quantitation of protein 
abundance but can also be applied to quantify changes in PTMs, such as phosphorylation. In 
an example of such an analysis, a phosphopeptide standard combining untreated or insulin 
treated mouse liver cell lines were spiked into samples derived from the liver of insulin 
treated or untreated mice. This method led to the identification of over 15,000 and 
quantitation of 10,000 phosphosites (Monetti et al., 2011). 
2.1.2 Isobaric tags for relative and absolute quantification (iTRAQ) 
Chemically labeling of proteins in different samples can also be used for their quantitation. 
One such technique uses isobaric tags for relative and absolute quantification (iTRAQ). In 
iTRAQ experiments, different chemical groups modify the primary amino group of either 
the N-terminus or lysine side chains of peptides in different samples (Ross et al., 2004). 
These differentially labeled peptides are pooled and analyzed by LC-MS/MS setup. Each of 
the labels has the same mass and therefore each peptide is visible in a single peak in the MS 
spectrum. However, fragmentation of that peak leads to formation of a low molecular mass 
reporter ion characteristic for each tag in the MS/MS spectrum that is used to quantify the 
relative amounts of the corresponding peptides and proteins. It is very important for this 
technique to distinguish peptides which have a similar mass and elute at the same time 
because this would lead to false ratios as both peptides contribute to the abundance of the 
same reporter ions (Ow et al., 2009; Zhang et al., 2010). In addition, it is crucial to ensure 
complete labeling of the sample. Moreover, side reactions of chemical labeling may be 
unavoidable, but can lead to false positive identifications of PTMs. For example, alkylation 
of a peptide mixture with iodoacetamide can produce a 2-acetamidoacetamide covalent 
adduct to lysine. This has the same atomic composition as a diglycine adduct of a 
ubiquitinated peptide after tryptic digest (Nielsen et al., 2008).   
2.1.3 Label free approaches 
In addition to the described labeling methods, so called “label-free” approaches that directly 
compare the abundance of peptides and proteins between samples are very attractive to 
analyze complex protein mixtures. Such approaches enable the analysis of samples which 
cannot be easily labeled. One type of label free quantitation approaches uses alignments of 
separate LC-MS/MS runs to compare peptide intensities between different samples. Recent 
advances in computational proteomics enable quantification of peptides from less complex 
samples by this approach (Mueller et al., 2008; Wong and Cagney, 2010). However, the 
accuracy of this approach is still somewhat lower compared to measurements from 
metabolic labeled samples. The analysis is particularly challenging for PTMs. Post 
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translational modified peptides are generally of low abundance and even small changes can 
have important effects on the cell. 
Sometimes only a few modified peptides are of interest for the question under 
consideration. In these cases, proteomics can be targeted to sequencing to a subset of 
previously identified peptides (Schmidt et al., 2009). One method to achieve this, called 
multiple reaction monitoring (MRM), is performed on so called triple quadrupole mass 
analyzers. In the first quadrupole, peptides of interest are isolated by their mass. The second 
quadrupole is a collision cell where the peptides are fragmented. The last quadrupole is set 
to some specific fragments that are characteristic for the peptide. The advantage of MRMs 
over unbiased approaches is the high sensitivity and speed (Kitteringham et al., 2009; 
Malmstrom et al., 2009; Wolf-Yadlin et al., 2007). However, false positive rates in these 
experiments can be high due to limited resolution of the quadrupole instruments compared 
to orbitraps. In alternative approaches using high resolution orbitrap instruments, the 
specific m/z of peptides of interest are written in an “inclusion list” (Jaffe et al., 2008). 
Whenever a peptide of this m/z is found in the MS spectrum it is selected for fragmentation 
and MS/MS analysis. If higher sensitivity of the instrument is required, selected ion 
monitoring (SIM) scans can be used to survey one or several pre-defined ranges of the m/z 
spectrum rather than a full spectrum during the chromatography run (Michalski et al., 
2011). 
2.2 Posttranslational modifications 
Quantitative proteomics can detect changes of the abundance of proteins in a whole 
proteome from cells in different conditions. In addition biological activity of proteins 
varies and is often regulated by PTMs. Therefore, it is important to measure changes of 
PTMs spatially and temporarily. MS is ideal to study PTMs because it can detect specific 
mass shifts due to the modification and assign its exact position in the amino acid 
sequence. 
2.2.1 Phosphorylation 
The most studied PTM is phosphorylation of the amino acids serine, threonine or 
tyrosine. Phosphorylation is important for many cellular processes. Protein 
phosphorylation conventionally is analyzed by 32P labeling, band shifts on SDS-PAGE 
gels or the detection of phosphorylated residues by site-specific antibodies. While these 
techniques yielded great insights, they focus usually on just one or a few proteins at a 
time. To study the complexity of signaling networks, systematic methods to study 
phosphorylation of many proteins at the same time are required. MS-based methods 
analyzing phosphorylation of proteins by detecting the phosphorylated peptides resulting 
from their digestion require enrichment of phosphorylated peptides to overcome their 
low abundance in cells. Several different methods have been established to enrich 
phosphorylated peptides. Antibodies specific for a specific phosphorylated amino acid, 
e.g., phospho-tyrosine, are used. These enrichment methods are very useful to study a 
specific phosphorylation species. A different enrichment method is immobilized metal 
(e.g., Fe3+) affinity chromatography (IMAC) (Corthals et al., 2005; Muszynska et al., 1992). 
With IMAC, all phosphopeptides are enriched due to the interaction between negatively 
charged phosphate groups and the immobilized positive metal ions. A similar technique 
uses TiO2 to complex phosphorylated peptides on a resin by their charge (Pinkse et al., 
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2004). In contrast to IMAC, phosphopeptide enrichment by TiO2 requires a competitor for 
the binding sites, such as dihydrobenzoic acid (DHB) or lactic acid, to exclude 
unphosphorylated negatively charged peptides (Larsen et al., 2005). A drawback of these 
competitors is possible contamination of the MS instruments by the competitor. In 
organisms of relatively low proteome complexity, such as Saccharomyces cerevisiae, this 
setup was sufficient to identify 5534 phosphosites (Soufi et al., 2009). However, due to the 
much higher complexity of the mammalian phosphoproteome, some studies use a pre-
fractionation step of peptides before phosphopeptides enrichment, e.g., by strong cation 
exchange chromatography (SCX) (Villen and Gygi, 2008). 
After enrichment of phosphorylated peptides, samples are analyzed by LC-MS/MS. To 
identify phosphorylated peptides and assign the localization of the phosphorylation site 
with high confidence, distinct fragmentation methods have been used. Collision induced 
dissociation (CID) fragmentation often results in a neutral loss because the phosphoester 
bond is relatively fragile. The resulting lost ions of 98 or 80 Da were used to scan specifically 
for phosphorylated peptides. However, this phenomenon often dominates the MS/MS 
scans (Tholey et al., 1999) and leads to reduced backbone fragmentation. For efficient 
identification of phosphorylated peptides in ion traps, the neutral loss signal can be isolated 
after MS/MS and subjected to additional CID to yield a MS3 spectrum (Jin et al., 2004). 
Multistage activation virtually combines MS2 and MS3 by parallel excitation and 
fragmentation (Schroeder et al., 2004). Even with multistage activation, fragmentation of 
phosphopeptides can be insufficient to identify the peptide sequence or to assign the 
phosphorylation site correctly with high confidence. Recent technical developments allow 
for different fragmentation techniques. Electron capture dissociation (ECD) or electron 
transfer dissociation (ETD) lead to sole backbone fragmentation between N and C bonds 
thereby generating c and z ions (Syka et al., 2004; Zubarev et al., 2000). PTMs unstable 
during CID fragmentation therefore stay intact with ETD fragmentation and make site 
specific assignment easier. Higher collision energy dissociation (HCD) uses the same 
principle of CID but higher collision energies, thus efficiently fragmenting the peptide 
backbone even in the presence of a low energy bond to a PTM. A recent study used a LTQ 
OrbitrapVelos to analyze both the precursor ion and its peptide fragments after HCD with 
high resolution in an orbitrap. This so called “high-high” technique yielded up to 16,000 
identified phosphorylation sites with high confident assignments (Nagaraj et al., 2010).  
Data quality is a particularly important issue for large scale PTM studies. For example, it is 
possible to identify a phosphorylated peptide with high confidence (>99%), but it is 
sometimes impossible to assign its site with high confidence between two adjacent serines. 
Therefore large scale datasets should always contain a peptide identification score and a 
PTM localization score (Beausoleil et al., 2006; Gnad et al., 2011; Olsen et al., 2006).  
2.2.2 Glycosylation 
Although phosphorylation is by far the most studied PTM, MS can also be used to study 
other PTMs. Another example for a prominent PTM is N-glycosylation of asparagine 
residues occurring in the endoplasmic reticulum. N-glycosylation plays an important role in 
the assembly of complex organelles and is involved in many cellular processes, such as 
apoptosis and the immune response (Varki, 2009). Due to the complexity of sugar moieties it 
is very challenging to analyze N-glycosylated proteins or peptides by MS approaches. 
Additionally the abundance of N-glycosylated proteins is usually very low in comparison to 
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their unmodified counterparts. Thus, N-glycosylated proteins are enriched for analysis by 
affinity purification using lectins (Bunkenborg et al., 2004) or by chemical linkage of the 
sugar moiety to a solid phase (Zhang et al., 2003).  
After enrichment, samples are treated with a global deglycosylating enzyme leading to the 
deamidation of the asparagine residue to aspartic acid. The resulting mass increase of 0.9848 
Da can be detected in the precursor scan as well as in the peptide fragments (Kuster and 
Mann, 1999). Previously, N-glycosylated peptides were identified with low resolution of the 
peptide precursor mass. A recent study, using high resolution MS instead, mapped roughly 
6,400 N-glycosylation sites in different murine cell lines quantitatively (Zielinska et al., 
2010). 
2.2.3 Acetylation and methylation 
Other common PTMs are acetylation or methylation of lysines and arginines. These are 
reversible PTMs that change the charge of the amino acid thereby possibly regulating 
protein function. The most prominent example is histone acetylation or methylation, which 
regulates transcription. Acetylated or methylated peptides are relatively low abundant and 
specific enrichment is required, similar as in the case of phosphorylation analysis. 
Enrichment with antibodies which recognize the modified amino acid is generally 
performed prior to analysis by MS. A recent study identified an unexpected large number of 
acetylation sites. By using high resolution MS in combination with SILAC, 3600 acetylation 
sites were identified on 1750 proteins. Due to the low abundance of acetylated peptides, 
Choudhary et al used isoelectric focusing after enrichment of acetylated peptides to further 
reduce sample complexity (Choudhary et al., 2009). A previous study revealed an 
unexpected role of acetylation in mitochondrial function (Kim et al., 2006). A method to 
measure methylation quantitatively is heavy methyl- SILAC. In this approach, heavy 
methionine serves as the sole donor for the methyl group. The mass shift of the peptide 
containing the heavy versus light methyl groups is detected by high resolution mass 
spectrometry (Ong et al., 2004). 
2.2.4 Ubiquitination 
Ubiquitination of proteins is another PTM amenable to MS based proteomics. The protein 
ubiquitin is crosslinked to lysine residues on target proteins. Ubiquitination plays an 
important role in proteasomal degradation and endocytosis of plasma membrane proteins. 
Since ubiquitin is a protein, it can be tagged for subsequent affinity enrichment. HIS tagged 
versions of ubiquitin can be used to isolate ubiquitinated proteins by affinity purification, 
leading in one example to the identification of 110 ubiquitination sites on 72 proteins in 
Saccharomyces cerevisiae (Peng et al., 2003). Instead of isolating ubiquitinated proteins, a site 
specific antibody that detects the diGly motif of ubiquitinated peptides, yielded 374 
diglycine modified lysines on 236 ubiquitinated proteins from HEK293 cells (Xu et al., 2010). 
One problem analyzing ubiquitinated proteins are their very complex fragmentation 
spectra. In addition it is difficult to distinguish by MS analysis modification by ubiquitin or 
by other ubiquitin-like molecules, such as interferon-induced 17kDA protein (ISG15) that 
leave the same diGly tag after digestion. Furthermore, it is not possible to distinguish if a 
protein is mono- or polyubiquitinated by LC MS/MS since digestion of the proteins with a 
protease is necessary and cleaves polyubiquitin chains. For a representative analysis of post 
translational modified proteins see Figure 1. 
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Cells are grown (label free or SILAC) and lysed for protein extraction. Extracted proteins are digested 
with an endoproteinase (Trypsin; LysC) and resulting peptides are fractionated (strong cation 
exachange (SCX) or strong anion exchange (SAX) chromatography). Peptides are enriched by their 
PTMs (specific antibodies, IMAC, TiO2, lectin affinity). Enriched peptides are fractionated by nano-flow 
LC and directly injected by electrospray ionization into the MS. Relative abundances of peptides are 
quantified by the first, full-scan MS event (MS). Peptide identification and determination of the PTM is 
achieved by fragmentation (CID, HCD, ETD, ECD) in the second stage of MS (MS/MS). 
Fig. 1. Workflow for quantitative proteomics of post translational modified proteins.  
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3. Spatial analysis of the cellular proteome 
3.1 MS-based proteomics approaches to map protein composition of organelles 
Each organelle is composed of a specific set of proteins that contribute to its function and 
that allow for communication with the rest of the cell. The content of organelles is highly 
dynamic and includes resident as well as transient proteins coming from and going to other 
compartments in the cell. Traditionally, to identify protein localization, cell biologists 
employ protein tagging by fluorescent labels or subcellular fractionation of cells in 
combination with detection of proteins by immunolabeling. These techniques have been 
successfully applied over many years and were adapted to high throughput studies, for 
example to tag nearly the complete proteome of budding (Huh et al., 2003) or of fission 
yeast (Matsuyama et al., 2006). However, technical limitations (e.g., absence of homologous 
recombination in many systems) and the enormous effort required for these approaches 
impede its application to more complex systems, such as mammalian cells. Therefore, 
organelle proteomics based on LS-MS was developed into a complementary approach that 
has made valuable contributions to the elucidation of organelles’ inventory in many 
systems. In this approach, organelles or parts thereof, including protein complexes, are 
purified biochemically and analyzed by MS-based techniques. 
3.1.1 MS based proteomics of purified organelle 
For few compartments, such as nucleus or mitochondrion, that are rather easy to isolate 
with high purity, MS-based proteomics has yielded protein inventories (Andersen et al., 
2002; Taylor et al., 2003). These and all other organellar proteomics experiments usually start 
with cell disruption under mild conditions designed to maintain organelle integrity. 
Organelles are then purified from crude cell extracts by differential centrifugations and are 
then processed for MS analysis. In this scheme, separation of organelles depends on their 
sedimentation velocity, a function of their size and density. Generally purification is 
improved by combining velocity sedimentation centrifugation with density gradient 
centrifugation (Michelsen and von Hagen, 2009; Wiederhold et al., 2010). Alternatively, 
higher purity is obtained by affinity purification using e.g., an antibody directed against a 
surface protein of the organelle, free flow electrophoresis (Islinger et al., 2010) or by 
modification of organelles density. An example for the latter is the report of phagosomes or 
endosomes inventories isolated after flotation gradient. In these cases, latex beads of 
different diameters can be internalized either by phagocytosis (Duclos and Desjardins, 2011; 
Jutras et al., 2008) or endocytosis (Duclos et al., 2011) and the resulting organelles are 
purified by a single step flotation gradient centrifugation before analysis by MS.  
For some organelles, no efficient purification schemes exist based solemnly on differences of 
density or sedimentation. Therefore, in some instances, chemical modification is used to 
facilitate the purification. For example, cell surface modification by cell impermeable 
chemicals is commonly used to modify plasma membrane proteins from the extracellular 
environment. In such strategy, plasma membrane proteins are covalently linked to biotin, 
which in turn is used as an affinity tag for subsequent purification on a column carrying 
streptavidin. Cell surface modification relying on different chemical properties of proteins 
such as the reactivity of primary amines (N-termini of proteins and side chains of lysines, 
(Elia, 2008; Scheurer et al., 2005), thiols (Laragione et al., 2003) or of carbohydrates 
(Teckchandani et al., 2009) have been developed to analyze the proteome of plasma 
membranes in normal (Zhao et al., 2004) and in pathological conditions (Hubbard et al., 
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2011; Yang et al., 2011) or to identify the dynamic proteome of the plasma membrane 
(Christiano et al., 2010).  
3.1.2 Differential proteomics 
Despite the remarkable success of these simple organelle proteomics approaches in some 
cases, formidable technical challenges to obtain pure organelles remain. Particularly in 
combination with highly sensitive mass spectrometers, simple purification schemes often 
result in the identification of large numbers of proteins. It is difficult to determine which 
ones among them are bona fide constituents of the target organelle and which ones are 
contaminants. One solution to overcome this limitation is the application of differential 
proteomics to subtract the proteins in the fraction in which the target organelle is found 
from a closely resembling fraction containing the most prominent contaminants. For this 
approach to work, the target organelle of interest should be enriched to the highest possible 
degree in one fraction, but be absent completely from the control fraction. This control 
sample could be as simple as a crude cell extract devoid of the target organelle, or better, 
reflect a similar purification in the absence of the organelle. After analysis of both samples, 
proteins that have been exclusively identified in the fraction enriched in the target organelle 
are considered as genuine proteins. In this approach, the accuracy of the obtained results 
strongly depends on the quality of two different MS analyses, as missing a protein in the 
control will lead its assignment to the target organelle. This point is critical considering the 
variability of analysis inherent to many MS approaches. For example, identification of a 
particular protein depends on different properties of the protein (such as abundance in the 
sample, ability of its peptide to be ionized in the mass spectrometer), as well as the MS 
methodology used. Failure to detect a protein does not necessarily mean it is absent from 
the sample. In differential proteomics approaches, this may lead to false negative or positive 
results, if a protein is randomly not detected in either the organelle enriched or the control 
fraction, respectively. Moreover, as sensitivity of MS analysis is improved and hence the 
number of identified proteins in each sample increases, the lists derived from each of the 
two fractions will more and more overlap, since proteins are likely to differ only in 
abundance and not strictly be absent from one sample. Thus, a large set of false negative 
proteins of the target organelle may be subtracted due to their identification in both 
samples.  
3.1.3 Quantitative organellar MS-based proteomics 
Quantitative proteomics is particularly useful in cases where sufficient enrichment for a 
specific organelle cannot be achieved. For example, organelles of the secretory pathway are 
similar to each other in their physical properties, with their content dynamically exchanging 
between them. Methods that only catalogue proteins in a sample cannot provide 
information on the dynamic behavior of proteins and are prone to detect contamination 
from co-purifying organelles. Intensive efforts have focused on sample preparation prior to 
MS. Successful strategies combine gradient profiling and quantitative MS-based proteomics.  
Such strategies rely on partial separation and distribution of subcellular compartments 
along density gradients. In protein correlation profiling (PCP) protein abundance profiles 
along the gradient are obtained by MS analysis and matched to profiles of known organelle 
markers. In this strategy, the accuracy of the quantification is a critical parameter to obtain 
reliable mapping of the organelle constituents. To date MS-based quantitative PCP analyses 
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have been performed using label free (Andersen et al., 2003) and SILAC quantitation 
(Dengjel et al., 2010). SILAC-PCP allows determination of accurate profiles. In that case, two 
independent gradients are obtained from two differently labeled cells. A fraction enriched 
for the organelle of interest is isolated from a gradient and spiked into each fraction of the 
other gradient (with a ratio 1 to 1). Profiles based on SILAC ratios can be extracted from 
each fraction of the gradient. Genuine proteins from the organelle of interest will show the 
highest ratio (close to one) in the organelle fraction, but have lower fractions elsewhere in 
the profile. In contrast, contaminants have higher ratios in other fractions that represent the 
organelles that they mostly purify with (Figure 2). Such approaches rely on the 
reproducibility of the gradient separation. An alternate gradient-based approach, 
localization of proteins by isotope tagging (LOPIT) has been successfully applied to plant  
 
 
PCP-SILAC: A light labeled (L) fraction enriched in a target organelle by gradient centrifugation is 
spiked into each fraction of a gradient of heavy (H) labeled cells Then, each combined fraction is 
analyzed independently. H/L ratios are extracted for proteins in all fractions and then abundance 
profiles are estimated. LOPIT: Specific organelle enriched fractions from a gradient are separated and 
labeled separately with different iTRAQ reagents. Fractions are pooled and processed into peptides. 
Then, the fraction is analyzed in a single MS run. Ratios from pair wise analyses are extracted and 
submitted to multivariate data analyses to identify genuine proteins. 
Fig. 2. Gradient Profiling based organelle proteomics.  
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organelles (Dunkley et al., 2004; Lilley and Dunkley, 2008). In that case, several organelle-
enriched fractions from one gradient are separately labeled with different iTRAQ reagents 
and pooled. Ratios derived from pair-wise comparisons are analyzed by multivariate data 
analyses to assign organelle localization to the proteins identified. (Figure 2) 
3.2 Protein complexes 
Proteins interact with each other to form complexes that contribute to cellular functions. 
Therefore, identifying protein interactions is of critical importance to unravel mechanisms 
underlying cellular functions. To identify complexes, affinity purification-based MS (AP-
MS) is the method of choice: Prior to MS analysis, protein complexes are purified with 
affinity matrices that bind to one subunit of the complex. The confident identification of true 
binders to the bait protein relies on the comparison with a good control fraction of the 
affinity purification. The emergence of affinity tags and robust antibodies greatly 
contributed to the success of AP-MS. 
The use of affinity tags is particularly attractive because it allows standardizing procedures 
that can be applicable to any system or protein. To date, a wide variety of tags has been used 
in AP-MS ranging from small peptides to proteins of several kDa. Fluorescent tags, such as 
green fluorescent protein (GFP), are common because they can also be used for live cell 
imaging. Furthermore, GFP purification allows recovery of most of the GFP-fused protein 
from a complex mixture in a single step. In this approach, proteins co-purifying with the 
bait are compared to a control condition where only the GFP protein is expressed (Figure 3 
B). Nevertheless, tag insertion might affect protein functions or prevent/trigger interactions 
with other proteins. Moreover, expression levels of fusion protein can be significantly 
different compared to their native counterparts and can affect binding capacities. Therefore, 
when efficient and specific antibodies are available, it is preferable to rely on purification of 
the native protein subunits to purify complexes. In that case, the control fraction can be 
obtained by incubating lysates with the beads alone (Trinkle-Mulcahy et al., 2008) or by 
depleting the protein of interest by RNA interference (quantitative immunoprecipitation 
combined with knockdown, QUICK) (Selbach and Mann, 2006) (Figure 3 A). Recently, 
Hubner et al. (Hubner et al., 2010) described quantitative bacterial artificial chromosome 
interactomics (QUBIC), using tagged proteins expressed under endogenous control in 
mammalian cells. Identification of interacting partners is achieved by robust and efficient 
affinity purification based on the GFP tag (Hubner and Mann, 2011; Vermeulen et al., 2010). 
However, most protein-protein interactions are dynamic and are hardly assessed by single 
AP-MS experiments. Depending on internal or external cues protein binding specificities 
can be modulated, e.g., by post-translational modification. This can result in their release 
from or recruitment to specific protein complexes thus potentially affecting their function(s) 
or their localization.  
At steady state, different forms of a protein are present in the cell which can hinder the 
discrimination among its interactors. A solution to this problem can be to use exogenous 
baits corresponding to a specific state of the protein of interest or of a peptide to identify 
interactions specific to a particular state. Different strategies have been developed for the 
identification of genuine interactors with high confidence. Generally, single step 
purifications are associated with a large number of contaminants. Lower background signal 
is achieved using more stringent purification, for instance by sequential purification using 
two affinity tags (tandem affinity purification; TAP). In TAP, two tags separated by a  
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A) Immunoprecipitation of endogenous proteins. Complexes from heavy (red) and light (green, control) 
labeled cells are purified using antibody-conjugated beads that target a specific subunit. Then the 
fractions are pooled before sample preparation and subsequent MS analysis. Control fraction can be 
obtained by using a cell lysate devoid of the target subunit by siRNA (QUICK) or by incubating a total 
lysate with the beads alone. B) One step purification of tagged proteins. A tagged subunit is expressed 
in heavy labeled cells (red). Using affinity columns, protein complexes are affinity purified using the tag 
and then eluted before being pooled with the control light fraction (green). After sample preparation the 
combined fraction is analyzed by MS. The control light fraction is obtained by expressing the tag alone 
in the cells. 
Fig. 3. Affinity purification based MS (AP-MS).  
cleavage site are fused to the protein of interest. In a first step the  complex is purified with 
the fusion protein using the first tag, then the protein of interest (along with its interactors) 
is released from the affinity matrix by specific cleavage of the tag before performing a 
second round of purification with the remainder of the tag. Different combinations of tags 
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have been combined and TAP strategies have been extensively used for AP-MS purification 
in many model systems (Gavin et al., 2006; Krogan et al., 2006). However, one drawback is 
the loss of weak interactors during stringent purification. A compromise is achieved by 
inserting a cleavage site between a tag and the protein of interest thus reducing the 
number of treatments and decreasing significantly the number of non-specific binders 
(Aguilar et al., 2010). In case of weak interactions, complexes can be fixed by treating with 
cross-linking chemicals either in live cells (Stingl et al., 2008; Yong et al., 2010) or cell 
lysates (Sinz, 2010). 
In general, quantitation greatly helps to discriminate false positive from true interactors. 
SILAC quantitation is more accurate and has advantages for protein complexes that are 
difficult to purify and where enrichment over background is smaller. As in all SILAC 
experiments, two differently labeled samples, here a control and a sample enriched in the 
target complex, are mixed and relative abundances of protein ratios are extracted from the 
MS spectra. In case of AP-MS, background proteins have a ratio of one as they bind as 
efficiently in both conditions. In contrast, true interactors have a high ratio as they are 
preferable purified from the labeled sample enriched in the complex of interest. Samples can 
be mixed either before (purification after mixing, PAM, (Wang and Huang, 2008)) or after 
purification (mixed after purification, MAP). The main drawback of PAM strategies is that 
dynamic interactions result in equilibrium between the light and heavy form during the 
purification, thus decreasing the observed ratio even for true interactors. 
4. Temporal analysis of proteomes 
4.1 Quantification of protein turnover by pulsed SILAC 
Protein turnover and protein degradation are critical for numerous biological processes, 
including the cell cycle, signal transduction and apoptosis. Organelle proteomes change 
over time and can be quickly adapted to respond to changing conditions. Therefore, 
unraveling mechanisms that determine protein abundances is important for understanding 
organelle dynamics and regulation.  
In general, quantitative approaches described before can be employed to gather snapshots of 
protein repertoires over time or in different conditions. However, such approaches quantify 
abundance changes of a given protein but fail to address what are the mechanisms 
underlying protein dynamics (decrease/increase turnover). Pulse-chase isotope tracer-based 
methods have been the method of choice to study protein degradation for decades. In such 
approaches, cells or animals are first metabolically pulse-labeled with radioisotope tracers 
(most commonly 3H, 15N, 35S are used). After a chase period concomitant with the beginning 
of the experiment, loss of the radiolabel from the protein of interest is followed by 
scintillation or autoradiography as a readout of protein degradation. Such classical pulse 
chase experiments have been successfully translated to protein turnover analyses by MS. In 
MS-based turnover analyses, cells are only pulsed. For cells in culture, the most common 
approach is a modification of SILAC. Instead of combining two differently labeled cell 
populations, cells are pulsed with stable isotope containing amino acids (pSILAC). The 
replacement of amino-acids in proteins is followed by MS analysis over time to extract 
turnover rates. Similarly to results from a standard SILAC experiment, pSILAC yields two 
forms of the same peptide. At the time point corresponding to the half-life (t1/2) of a specific 
protein, the intensities of the light and heavy peaks for a peptide pair derived from this 
protein are equal (Figure 4). 
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Light labeled cells (green) are pulsed with heavy amino acid containing medium (red). Cells are harvested 
at different time points, lysed, processed into peptides and analyzed independently. Ratios H/L are 
derived from intensities of heavy (H, red) and light (L, green) peptide peaks in the MS spectra. Note, at 
protein half life (T1/2) intensity of light and heavy peptides are equal in the mass spectra. Then loss of light 
label can be calculated over time and turnover rates are extracted from non-linear curve fitting. 
Fig. 4. pSILAC to analyze protein turnover.  
To date, pSILAC has been mostly applied to cells in culture: Saccharomyces cerevisiae (Pratt et 
al., 2002), Streptomyces coelicolor (Jayapal et al., 2010) and human cells (Doherty et al., 2009; 
Schwanhäusser et al., 2011; Zee et al., 2010). Schwanhäusser et al. measured protein 
abundances and turnover of more than 5,000 proteins in HeLa cells. Combination of pSILAC 
with metabolic pulse labeling of mRNA in the same cells enabled comparison of proteins 
and mRNAs turnover at an unprecedented depth.  
At steady state, protein levels are constant. Therefore synthesis and degradation rates are 
equal. This feature is critical when comparing proteome turnover, but this assumption may 
not always be fulfilled when comparing different conditions. An alternative approach 
overcoming this limitation is to follow synthesis and degradation independently from each 
other. To follow regulation of protein synthesis during changes of cellular iron, 
Schwannäusser et al. combined control (non-treated) and iron-treated HeLa cells that have 
been differently SILAC pulsed (Schwanhäusser et al., 2009). At the beginning of the 
experiment, cells in both conditions were identically light labeled (L). Concomitantly with iron 
treatment, cells were differently pulsed with medium (M) or heavy (H) amino-acids. Then cell 
lysates were combined and analyzed by MS. The relative abundance of newly synthesized 
proteins in both conditions was then extracted from intensities of the M and H peaks in the MS 
spectrum. As expected, most of the 1311 proteins identified in this study do not present 
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specific synthesis regulation upon iron treatment (ratio M/H of 1). However proteins such as 
ferritins show up to 13 fold synthesis upregulation compared to normal conditions.  
4.2 Analysis of cell signaling as an example of dynamic PTM analysis 
Unbiased, quantitative proteomics enables studying signaling networks in a time resolved 
manner. Protein abundance is often the output of complete signaling cascades. MS can 
detect PTM changes as an early response to system perturbations, as well as the changed 
protein abundance as the output of a signaling cascade.  
Combination of phosphoproteomics with quantitative approaches such as SILAC enables 
the temporal analysis of signaling networks. In these experiments, cells are labeled in 
different SILAC states and stimulated for different periods of time. Applying this 
methodology, Olsen et al. quantified 6,600 phosphorylation sites in HeLa cells at 5 different 
time points after stimulation with epidermal growth factor (EGF) (Olsen et al., 2006). These 
experiments revealed insights into the early response of cells to EGF stimulation. 
Interestingly, this study showed that different phosphorylation sites on the same protein can 
react with completely different timing to a stimulus. Such results are easiest obtained by MS 
because it allows for detection of phosphorylation changes at particular amino acids of the 
protein sequence. Effects at different sites can otherwise easily be missed with classical 
methods that detect total phosphorylation of a protein. Other studies used a combination of 
SILAC labeling and different drug treatments to analyze the proteome and 
phosphoproteome of HeLa cells over the complete cell cycle (Olsen et al., 2010). A similar 
study in Saccharomyces cerevisiae used a mutant of the cell cycle kinase Cdk1 that allows 
inhibition of the kinase with an ATP analogue (Holt et al., 2009). Another recent 
phosphoproteome revealed great insights into the early differentiation of embryonic stem 
cells after stimulation with a diacylglycerol analogue. This study yielded roughly 20,000 
phosphosites with almost 50% of them responding to the stimulus (Rigbolt et al., 2011). 
These experiments help to dissect complex signaling networks since proteins are clustered 
into certain groups according to their response. In addition, the high resolution datasets 
serve as a great resource for the scientific community and provide data for further analyses 
to generate models for signaling networks.  
5. Conclusion 
Quantitative mass spectrometry based proteomics emerged over the last few years as a 
crucial technique for cell biology and biochemistry research. The exciting developments in 
this field discussed in this chapter have provided unexpected aspects of organelle dynamics, 
protein turnover and PTMs. Future developments in methodology, computation and 
technical developments will make these technologies accessible for a larger group of 
scientists. This should help to generate more high quality datasets which will serve as a 
reference for the larger scientific community. In addition, integration of proteomics data 
with data from other system-wide approaches, such as genetic screens or transcriptome 
analysis, will help to understand complex biological processes.  
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